These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34291172)

  • 21. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
    Helton SG; Lohoff FW
    Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.
    Chawar C; Hillmer A; Sanger S; D'Elia A; Panesar B; Guan L; Xie DX; Bansal N; Abdullah A; Kapczinski F; Pare G; Thabane L; Samaan Z
    Addict Sci Clin Pract; 2021 Nov; 16(1):70. PubMed ID: 34838141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic considerations for migraine therapies.
    Capi M; Gentile G; Lionetto L; Salerno G; Cipolla F; Curto M; Borro M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1161-1167. PubMed ID: 30362834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
    Williams EC; Young JP; Achtmeyer CE; Hendershot CS
    J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asthma pharmacogenetics: responding to the call for a personalized approach.
    Ortega VE; Wechsler ME
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):399-409. PubMed ID: 23799335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies.
    Morley KC; Perry CJ; Watt J; Hurzeler T; Leggio L; Lawrence AJ; Haber P
    Expert Opin Pharmacother; 2021 Jul; 22(10):1291-1303. PubMed ID: 33615945
    [No Abstract]   [Full Text] [Related]  

  • 27. Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.
    Tantisira KG; Damask A; Szefler SJ; Schuemann B; Markezich A; Su J; Klanderman B; Sylvia J; Wu R; Martinez F; Boushey HA; Chinchilli VM; Mauger D; Weiss ST; Israel E;
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1286-91. PubMed ID: 22538805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses.
    Hart AB; Kranzler HR
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1312-27. PubMed ID: 26110981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the impact of pharmacogenetics on personalized medicine: A systematic review.
    Amaro-Álvarez L; Cordero-Ramos J; Calleja-Hernández MÁ
    Farm Hosp; 2024 Feb; ():. PubMed ID: 38341366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of alcohol, nicotine and drug addiction treatments.
    Sturgess JE; George TP; Kennedy JL; Heinz A; Müller DJ
    Addict Biol; 2011 Jul; 16(3):357-76. PubMed ID: 21362114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacogenetics of antiplatelet agents: towards personalized therapy?
    Ahmad T; Voora D; Becker RC
    Nat Rev Cardiol; 2011 Aug; 8(10):560-71. PubMed ID: 21826075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse types of genomic evidence converge on alcohol use disorder risk genes.
    Dai Y; Hu R; Pei G; Zhang H; Zhao Z; Jia P
    J Med Genet; 2020 Nov; 57(11):733-743. PubMed ID: 32170004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics of OPRM1.
    Crist RC; Berrettini WH
    Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic mapping of pharmacogenetic regulatory variation.
    Raby BA
    Curr Pharm Des; 2009; 15(32):3773-81. PubMed ID: 19925428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine.
    Ortega VE; Meyers DA; Bleecker ER
    Pharmgenomics Pers Med; 2015; 8():9-22. PubMed ID: 25691813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
    Shah RR
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders.
    Walker LC; Lawrence AJ
    Expert Opin Investig Drugs; 2018 Jul; ():1-14. PubMed ID: 30019949
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.